ExtendMed vs. Within3
ExtendMed vs. Within3
Deciding which stakeholder engagement solution is right for your organization can be challenging. You need a clear understanding of your options and the differences between them. We know we're not the only platform provider in this space, which is why we want to be transparent about how we compare—and who we're best suited to serve.
ExtendMed was built exclusively for small to mid-size pharma, biotech and medical device companies that need both sophisticated engagement technology and strategic partnership. While Within3 focuses on scaling standardized SaaS for global enterprises, we provide flexible, customizable solutions wrapped in white-glove service.
When Mediar Therapeutics needed an advisory board platform, they chose us over Within3 for one simple reason: we gave them what they actually needed—hybrid sync/async engagement, no year-long commitment, dedicated strategic support and rapid feature customization. The result? Advisors averaged 5 hours of engagement each, with some providing 25+ insights that directly shaped their clinical development strategy.
We work best with small to mid-size pharma, biotech and medical device companies—not industry giants. We understand the challenge of leveraging limited resources to engage KOLs, convene advisory boards and build speaker programs. That's why our platform and service model are designed to give lean teams maximum impact at a fraction of traditional costs.
While Within3 focuses primarily on asynchronous engagement, ExtendMed supports both real-time virtual meetings and time-shifted discussions. Host live interactive sessions with polls and Q&A, then continue the conversation through discussion boards. Deploy surveys where responses stay private, enabling sensitive feedback. This combined approach gives teams wholly new capabilities for gathering insights.
You get more than software. Each client receives a dedicated senior program manager who provides development, implementation, training and ongoing support. We customize the platform to your specific needs, often responding faster than traditional SaaS models. We're an extension of your team, not a vendor.
We let you start with a 6-month pilot. Run a short-term steering committee engagement. Test the platform on one project before scaling. Our flexible approach lets you evaluate effectiveness without the year-long minimum agreements typical of larger platforms. Grow with us at your pace.
Beyond discussion boards, we offer resource centers where experts access materials on demand, survey tools with conditional logic for quantitative research and the ability to segment audiences for person-by-person feedback versus group dialogue. This integrated approach helps teams collect insights they simply couldn't before.
Stop juggling insights across multiple platforms. ExtendMed centralizes results from advisory boards, surveys and discussion forums, so you can analyze activities across them. See patterns across different engagement types, connect dots between stakeholder groups and generate comprehensive reports from one system.
Our size is a strategic advantage. You get senior healthcare technology experts on your account, not junior support staff. We can pivot quickly, add features within days rather than quarters, and provide the nimble partnership that large-scale SaaS companies can't match.
A biotech startup specializing in fibrosis treatment needed strategic insights from interdisciplinary experts but faced budget constraints that made Within3 unfeasible.
We delivered a hybrid virtual advisory board with both live meetings and asynchronous discussions.
Advisors contributed average of 5 hours each
Some experts provided 25+ individual insights
Actionable recommendations that advanced clinical development strategy
Stronger relationships with thought leaders across multiple specialties
Superior insights compared to in-person boards at fraction of the cost
You're a great fit if you:
Mediar Therapeutics needed rapid, cross-functional insights in fibrosis. We convened a virtual advisory board of top experts, facilitated real-time collaboration and fast-tracked the feedback loop.

A global oncology biopharma used Health Expert Connect™ to orchestrate 1:1s, a dinner forum and follow-ups across ASCO and EHA—centralizing schedules, compliance tracking and KOL analytics to deepen relationships at scale.
An inflammatory-disease company expanding into nephrology ran asynchronous boards, surveys and chart audits to learn the market fast, refine messaging and engage specialists every six weeks—accelerating entry with lower spend.
A small pharma prepping first launch scaled stakeholder engagement with a lean team, mixing virtual meetings and ongoing discussion to surface payer hurdles and patient insights early, de-risk and beat rivals to key KOLs.
In 25 years of working with vendors, ExtendMed stands at the top of the list. They’re strategic partners, arming my staff with vital statistics and sharing their experience and ideas for the future. They’re nimble and they understand our business. They’ve anticipated issues, recommended new directions and implemented our decisions efficiently.”

We feel your team does the best job out of any vendor we have used for virtual advisory boards.”
The virtual format enables more frequent touchpoints while reducing time commitments for busy specialists. We can build relationships and confidence across multiple specialty areas in ways that traditional in-person meetings never could. The platform makes it possible to engage specialists who would never attend a weekend conference but will participate in targeted discussions relevant to their practice."
Nobody wants to gamble on a complicated new system. That’s why we’ve made getting started with ExtendMed simple and supportive—from first conversation to long-term success.
We'll discuss your goals, current challenges and whether ExtendMed is the right fit for your needs.
See exactly how our platform supports your specific programs. If we're a fit, we'll work closely with your team to customize the solution.
Launch a pilot project with no long-term commitment. Prove the value, then expand at your pace.
Still have questions? Here are answers to the most common ones we hear from clients exploring Health Expert Connect™.
Within3 operates primarily as a SaaS platform provider, offering their technology with a more self-service approach suited to large pharmaceutical companies with established internal teams. ExtendMed combines platform technology with white-glove service, providing dedicated program managers, strategic consulting and hands-on support throughout the engagement lifecycle. Our hybrid model means you're not just getting software—you're getting a strategic partner who helps with program design, execution and analysis. For teams that need both technology and expertise, especially those without large internal resources, this full-service option can be invaluable.
We’ve heard that Within3 typically requires year-long minimum commitments, which makes sense for their enterprise client base running continuous global programs. ExtendMed offers more flexible terms, including short-term pilot projects starting at $20,000-$25,000, allowing you to test the platform's effectiveness for a single advisory board or speaker program before making a larger commitment. This flexibility is particularly helpful for small to mid-size companies, specific therapeutic area pilots or teams that need to prove ROI internally before scaling. It’s one of the biggest factors that pulls teams from Within3 to us.
Within3 is primarily built for asynchronous engagement, which works well for global programs where time zones make live meetings challenging. ExtendMed's Health Expert Connect™ platform supports both synchronous (live meetings) and asynchronous (discussion forums, surveys) engagement, often combining them in hybrid programs. This means you can bookend an advisory board with live sessions to build trust and rapport while using asynchronous discussions for deeper analysis between meetings. The flexibility to mix engagement formats based on your program goals (rather than being limited to one approach) can lead to richer insights and stronger expert relationships.
Within3 focuses on serving the largest pharma companies with complex, global asynchronous engagement needs. Their platform and pricing model reflect that enterprise focus. ExtendMed was specifically built for small to mid-size pharmaceutical, biotech and medical device companies, as well as the medical communications agencies that serve them. This means ExtendMed's workflows, pricing and support model are designed around the realities of smaller teams with limited resources. The platform can be licensed for independent use or run as a fully-managed service, depending on your internal capabilities and preferences.
Both platforms can be configured for different use cases, but they take different approaches. Within3 operates on a more standardized SaaS model, which provides consistency across its large client base. At ExtendMed, we emphasize high customizability, with the ability to adapt the platform to your specific SOPs, branding requirements and workflow preferences. For example, when Mediar Therapeutics needed specific features, we developed them in under a week. This agility can be particularly valuable when you have unique compliance requirements, specialized therapeutic area needs or want to integrate with existing systems like Veeva or Salesforce in specific ways.
This depends on your engagement model. If your agency is handling all program management and just needs technology access, either platform could work. However, ExtendMed specializes in partnering with agencies through white-labeled solutions, co-branded portals and backend support that keeps your agency front-and-center with clients while ExtendMed handles the technology and compliance infrastructure. Many agencies choose ExtendMed over Within3 specifically because they can offer their clients a complete solution—combining their content expertise with ExtendMed's engagement technology—without needing to build or maintain their own platform. ExtendMed essentially becomes an invisible partner that extends the agency's capabilities.
Since 2000, we've helped pharmaceutical, biotech and medical device companies—plus the agencies that serve them—deliver efficient stakeholder engagement that drives better decisions. Whether you're evaluating alternatives to Within3 or exploring engagement platforms for the first time, we're here to show you what purpose-built partnership looks like.